Bridgeway Capital Management’s Mustang Bio MBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-284
| Closed | -$84K | – | 1409 |
|
|
2022
Q4 | $84K | Sell |
284
-66
| -19% | -$19.5K | ﹤0.01% | 1242 |
|
|
2022
Q3 | $123K | Hold |
350
| – | – | ﹤0.01% | 1238 |
|
|
2022
Q2 | $154K | Sell |
350
-67
| -16% | -$29.5K | ﹤0.01% | 1146 |
|
|
2022
Q1 | $316K | Hold |
417
| – | – | 0.01% | 1061 |
|
|
2021
Q4 | $519K | Buy |
417
+25
| +6% | +$31.1K | 0.01% | 976 |
|
|
2021
Q3 | $792K | Sell |
392
-49
| -11% | -$99K | 0.02% | 896 |
|
|
2021
Q2 | $1.1M | Buy |
441
+30
| +7% | +$74.8K | 0.02% | 826 |
|
|
2021
Q1 | $1.02M | Buy |
411
+153
| +59% | +$381K | 0.02% | 854 |
|
|
2020
Q4 | $732K | Hold |
258
| – | – | 0.02% | 830 |
|
|
2020
Q3 | $609K | Hold |
258
| – | – | 0.01% | 823 |
|
|
2020
Q2 | $615K | Buy |
258
+27
| +12% | +$64.4K | 0.01% | 795 |
|
|
2020
Q1 | $465K | Hold |
231
| – | – | 0.01% | 794 |
|
|
2019
Q4 | $707K | Buy |
231
+94
| +69% | +$288K | 0.01% | 834 |
|
|
2019
Q3 | $334K | Buy |
137
+120
| +706% | +$293K | ﹤0.01% | 1075 |
|
|
2019
Q2 | $46K | Hold |
17
| – | – | ﹤0.01% | 1280 |
|
|
2019
Q1 | $43K | Sell |
17
-66
| -80% | -$167K | ﹤0.01% | 1317 |
|
|
2018
Q4 | $184K | Sell |
83
-17
| -17% | -$37.7K | ﹤0.01% | 1227 |
|
|
2018
Q3 | $446K | Hold |
100
| – | – | ﹤0.01% | 1172 |
|
|
2018
Q2 | $517K | Hold |
100
| – | – | 0.01% | 1118 |
|
|
2018
Q1 | $821K | Buy |
+100
| New | +$821K | 0.01% | 915 |
|